ASX:IMR Imricor Medical Systems (IMR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Imricor Medical Systems Stock (ASX:IMR) 30 days 90 days 365 days Advanced Chart Get IMR alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume27,486 shsAverage VolumeN/AMarket CapitalizationA$167.29 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota. Read More Receive IMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imricor Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMR Stock News HeadlinesImricor Medical Systems Expands Market Presence with New Securities QuotationSeptember 14 at 11:30 PM | tipranks.comImricor Medical Systems Expands ASX Quotation with New SecuritiesSeptember 7, 2025 | tipranks.comYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.September 16 at 2:00 AM | Priority Gold (Ad)Imricor Advances U.S. Market Expansion with FDA SubmissionAugust 31, 2025 | tipranks.comImricor Releases Shares from Voluntary Escrow, Boosting Market LiquidityAugust 28, 2025 | tipranks.comImricor Medical Systems Advances in Cardiac Ablation InnovationAugust 26, 2025 | msn.comImricor Medical Systems’ 1H 2025 Investor Presentation Highlights Global Expansion GoalsAugust 26, 2025 | msn.comHalf Year 2025 Imricor Medical Systems Inc Earnings Presentation TranscriptAugust 25, 2025 | gurufocus.comSee More Headlines IMR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Imricor Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Imricor Medical Systems investors own include Frequency Therapeutics (FREQ), Cue Biopharma (CUE), Provention Bio (PRVB), Gold Standard Ventures (GSV), Nuwellis (CHFS), BCB Bancorp, Inc. (NJ) (BCBP) and Atomera (ATOM). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryPharmaceutical Products Current SymbolASX:IMR CIKN/A Webwww.imricor.com Phone952-818-8400FaxN/AEmployees140Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$20.26 million Net Margins-2,458.31% Pretax MarginN/A Return on Equity266.83% Return on Assets-124.67% Debt Debt-to-Equity Ratio-146.38 Current Ratio1.46 Quick Ratio4.33 Sales & Book Value Annual SalesA$868.00 thousand Price / Sales0.00 Cash FlowN/A Price / Cash Flow25.56 Book ValueA($0.03) per share Price / BookN/AMiscellaneous Outstanding Shares270,180,000Free FloatN/AMarket CapA$167.29 million OptionableNot Optionable Beta0.26 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (ASX:IMR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imricor Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imricor Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMR Stock Alerts